Breast Cancer Clinical Trials

Showing 161-180 of 2,749 trials

COMPLETEDPHASE4

Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)

NCT03664687

REaCT ZOL will compare one 4 mg dose of Zoledronate vs. one 4 mg dose of Zoledronate given every 6 months for 3 years.

Early-stage Breast Cancer

Ottawa Hospital Research Institute211 participantsStarted Oct 2018

Brampton, Ontario, Canada • Hamilton, Ontario, Canada • Kingston, Ontario, Canada +3 more locations

RECRUITINGPHASE1/PHASE2

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

NCT04588545

The purpose of this study is to find out if radiation therapy followed by intrathecal trastuzumab and pertuzumab is safe and will result in improved survival in HER2 positive breast cancer which has metastasized to the leptomeninges.

HER2-positive Breast CancerLeptomeningeal MetastasisLeptomeningeal Disease

H. Lee Moffitt Cancer Center and Research Institute39 participantsStarted Dec 2020

Tampa, Florida, United States • Evanston, Illinois, United States

Comparing a Single-Dose vs. Twice Yearly Zoledronate in Patients With Early Stage Breast Cancer (REaCT-ZOL)

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

Related Searches

Cardiotoxicity of Cancer Therapy (CCT)

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer

A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases

Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy

A Study of MGC026 in Participants With Advanced Solid Tumors

Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

The MIND-BC Study: MIND Diet for Breast Cancer Cognition

Group Interventions for Breast Cancer Survivors

Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy

Precision Supplemental Imaging in Women With Dense Breasts

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung